Acumen Pharmaceuticals (ABOS) Non-Current Assets (2021 - 2026)

Acumen Pharmaceuticals' Non-Current Assets history runs 6 years deep, the most recent figure standing at $535000.0 for Q1 2026.

• In Q1 2026, Non-Current Assets fell 98.92% year-over-year to $535000.0; the TTM figure through Mar 2026 stood at $34.7 million (down 81.9% YoY), while the FY2025 annual figure was $581000.0, down 99.04% from the prior year.
• Non-Current Assets came in at $535000.0 for Q1 2026 at Acumen Pharmaceuticals, down from $581000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $67.8 million in Q3 2023 to a low of $535000.0 in Q1 2026.
• A 5-year average of $31.8 million and a median of $27.9 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 9526.85% in 2023 and plunged 99.04% in 2025, its largest moves.
• Acumen Pharmaceuticals' Non-Current Assets stood at $16.3 million in 2022, then surged by 290.64% to $63.5 million in 2023, then retreated by 4.45% to $60.7 million in 2024, then tumbled by 99.04% to $581000.0 in 2025, then slipped by 7.92% to $535000.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $535000.0, $581000.0, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison